On 28 September 2022, the World Anti-Doping Agency (WADA) published its 2024 List of Prohibited Substances and Methods, which will come into force on 1 January 2024. The delay in implementation was to provide an additional year to allow enough time for stakeholders to learn and adapt to this change.
The most significant change to the WADA list was the inclusion of Tramadol (an opioid pain medication used to treat moderate to moderately severe pain) after the WADA Executive Committee approved the recommendation of its List Expert Advisory Group. Other changes mainly deal with the addition of new examples of prohibited substances. It is important to note that according to WADA, “for a substance or method to be added to the List, it must be determined that it meets at least two of the following three criteria:
- It has the potential to enhance or enhances sport performance;
- It represents an actual or potential health risk to the athlete, and,
- It violates the spirit of sport.”
It is recalled that the List is one of the eight International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code).
In the following link you will find WADA’s Summary of Major Modifications and Explanatory Notes.
In addition, on 27 September 2023, the World Anti-Doping Ageancy (WADA) published a new Technical Document (TD), which was approved by WADA Executive Committee on 22 September 2023.
This 31-page document outlines the requirements for the production of laboratory documentation packages by laboratories, including instructions for producing the said packages by laboratories for analytical results. In addition, this TD “includes instructions for producing Athlete Biological Passport laboratory documentation packages.”
In the following link you will find the new Technical Document (TD)
https://www.wada-ama.org/sites/default/files/2023-09/td2023ldoc_final.pdf
This new Technical Document came into force on 1 October 2023.